UM171 saves another life
(University of Montreal) Developed in Canada, the UM171 molecule was used in a blood transplant by a Montreal medical team on a young man suffering from severe aplastic anemia, an autoimmune disease. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 30, 2020 Category: International Medicine & Public Health Source Type: news

Eltrombopag as bridging therapy to haematopoietic stem cell transplant in severe or very severe aplastic anaemia during the COVID19 pandemic (in adults), NHS England
Aplastic anaemia is a rare and serious bone marrow failure disorder causing a high risk of life-threatening bleeding and infections, and requiring frequent hospital admissions. Current definitive treatments for aplastic anaemia are stem cell transplant or immunosuppressive therapy with antithymocyte globulin and/or ciclosporin. Stem cell transplant is a procedure in which a patient receives healthy stem cells to replace damaged stem cells. Immunosuppressive treatment is where drugs are given to lower the body's immune response. Stem cell transplant and antithymocyte globulin treatment require hospital admission (Source: Cu...
Source: Current Awareness Service for Health (CASH) - July 14, 2020 Category: Consumer Health News Source Type: news

Eligible for two schemes but these patients still can't get money for transplants
Eleven-year-old Sameer from Bihar ’s Muzaffarpur district is suffering from aplastic anaemia, and needs Rs 12 lakh for a bone marrow transplant. You would think that’s not a big hurdle since his mother’s name figures in the list of Ayushman Bharat beneficiaries but unfortunately his condition isn’t covered by the scheme. (Source: The Economic Times)
Source: The Economic Times - December 22, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Aplastic anemia: Everything you need to know
Aplastic anemia is a rare condition that damages vital stem cells in the bone marrow. Learn about the symptoms and treatment options for aplastic anemia here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - October 24, 2019 Category: Consumer Health News Tags: Blood / Hematology Source Type: news

Study to Evaluate the Safety and Efficacy of the Combination Therapy of Ibrexafungerp (SCY-078) With Voriconazole in Patients With Invasive Pulmonary Aspergillosis (SCYNERGIA)
This is a multicenter, randomized, double-blind, two-arm study to evaluate the safety, tolerability, efficacy and PK of the combination therapy of SCY-078 plus voriconazole compared to those of voriconazole monotherapy in male and female subjects 18 years of age and older with a hematological malignancy (HM) or a myelodysplastic syndrome or aplastic anemia or hematopoietic cell transplantation (HCT) and a probable or proven invasive pulmonary aspergillosis based on EORTCMSG criteria. In addition, all subjects must be positive ( ≥0.5) for serum GMI. (Source: The Aspergillus Website - updates)
Source: The Aspergillus Website - updates - July 3, 2019 Category: Respiratory Medicine Authors: GAtherton Source Type: news

Woman sent home with paracetamol by her GP turns out to have rare blood disease
Annie Lovegrove, from Ipswich, was told she had tonsillitis and sent home with painkillers but the next day she was taken to A&E and doctors realised she had aplastic anaemia. (Source: the Mail online | Health)
Source: the Mail online | Health - July 1, 2019 Category: Consumer Health News Source Type: news

Employers Are Steering Workers Toward Controversial Stem Cell Therapies
A Midwestern grocery chain, Hy-Vee, is taking an unusual—and highly controversial—approach to reducing health care costs. Before employees in certain cities can undergo knee replacement, they first must visit a stem cell provider. Hy-Vee has contracted with one of the U.S.’ leading stem cell companies—Regenexx, based in Des Moines, Iowa—that claims injections of concentrated bone marrow or platelets can help patients avoid expensive joint surgery. Regenexx has persuaded over 100 employers to include its services in their health insurance plans. In a marketing booklet, Regenexx, whose injection...
Source: TIME: Health - June 19, 2019 Category: Consumer Health News Authors: Liz Szabo / Kaiser Health News Tags: Uncategorized Healthcare medicine Source Type: news

Who Blood Tranfusions Help: Layla Wigmore ’s Story
Layla Wigmore is an 8-year-old, third grader with a big smile and a big heart for helping others. In March 2018, she was diagnosed with severe aplastic anemia, a rare ... The post Who Blood... {This is a content summary only. Click the blog post title to continue reading this post, share your comments, browse the blog and more!} (Source: Red Cross Chat)
Source: Red Cross Chat - April 17, 2019 Category: International Medicine & Public Health Authors: American Red Cross Tags: Blood aplastic anemia blood donation blood donor blood transfusion game of thrones Layla Layla Wigmore Source Type: news

FDA Approves Promacta (eltrombopag) for First-Line Severe Aplastic Anemia
Basel, November 16, 2018 - Novartis announced today that the US Food and Drug Administration (FDA) has expanded the label for Promacta (eltrombopag) to include first-line treatment for adults and pediatric patients two years and older with severe... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - November 16, 2018 Category: Drugs & Pharmacology Source Type: news

Bleeding gums and all-day nosebleeds turn out to be a sign of a deadly bone marrow disease 
Natalia Slazak, 31, from Buckinghamshire, was diagnosed with aplastic anaemia, a condition which causes red and white blood cells and platelets to drop to dangerously low levels. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2018 Category: Consumer Health News Source Type: news

FDA expedites review of Novartis drug Promacta(R) for first-line severe aplastic anemia (SAA)
Promacta receives FDA Priority Review for first-line treatment of SAA based on data showing 52% complete response rate and 85% overall response rate when added to standard immunosuppressive therapy (IST) Regulatory action underscores the treatment poten... Biopharmaceuticals, FDA Novartis, Promacta, eltrombopag, aplastic anemia, TPO receptor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 30, 2018 Category: Pharmaceuticals Source Type: news

Strangers Become Heroes Everyday: How Your Platelet Donations Can Help Save Lives
When some people hear “blood donation” they feel queasy or uncomfortable but for patients who need blood transfusions, they feel grateful. Liviya Anderson was diagnosed with aplastic anemia when she... {This is a content summary only. Click the blog post title to continue reading this post, share your comments, browse the blog and more!} (Source: Red Cross Chat)
Source: Red Cross Chat - May 14, 2018 Category: International Medicine & Public Health Authors: American Red Cross Tags: Blood aplastic anemia blood donation Liviya Platelet Donation platelets Source Type: news

Celiac Disease Associated With Aplastic Anemia in a 6-Year-Old Celiac Disease Associated With Aplastic Anemia in a 6-Year-Old
Many hematological disorders have been associated with celiac disease. This case represents the fourth associated with aplastic anemia in children--might it be more common than thought?Journal of Medical Case Reports (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 20, 2018 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Two year old boy needs life-saving donors after rare blood disorder diagnosis
CANCER symptoms affects almost 360,000 new people in the UK every year. This International Childhood Cancer Day, blood cancer charity Anthony Nolan are raising awareness of rare disorders, as two-year old Jacob needs a stem cell donor for his aplastic anaemia condition. (Source: Daily Express - Health)
Source: Daily Express - Health - February 15, 2018 Category: Consumer Health News Source Type: news

Novartis drug Promacta(R) receives FDA Breakthrough Therapy designation for first-line use in severe aplastic anemia (SAA)
Data supporting designation showed over half of treatment-naïve SAA patients achieved complete response with Promacta when given with standard immunosuppressive therapy, with overall response rate of 85%[1] Promacta is the only TPO receptor agonist... Biopharmaceuticals, FDA Novartis, Promacta, eltrombopag, aplastic anemia, TPO receptor agonist (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 4, 2018 Category: Pharmaceuticals Source Type: news

Novartis' Promacta receives FDA breakthrough designation for new indication
ZURICH (Reuters) - Novartis drug Promacta has received breakthrough therapy designation from the U.S. Food and Drug Administration for first-line treatment of severe aplastic anemia (SAA). (Source: Reuters: Health)
Source: Reuters: Health - January 4, 2018 Category: Consumer Health News Tags: healthNews Source Type: news

Can Gout Cause Aplastic Anemia?
Title: Can Gout Cause Aplastic Anemia?Category: Doctor's& Expert's views on SymptomsCreated: 10/24/2017 12:00:00 AMLast Editorial Review: 10/24/2017 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - October 24, 2017 Category: Rheumatology Source Type: news

Immunosuppressant Response Predicts Aplastic Anemia Survival
Overall survival superior in therapy responders; shorter relapse - free survival with partial response (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - September 7, 2017 Category: Cancer & Oncology Tags: Oncology, Journal, Source Type: news

Gamida Cell launches severe aplastic anemia trial
Gamida Cell said today that the first patient has been transplanted in a study of its CordIn product for patients with severe aplastic anemia or hypoplastic myelodysplastic syndrome. The product is designed for patients with rare genetic diseases who have no fully-matched donors for a bone marrow transplantation. Gamida Cell said it is also evaluating its CordIn therapy for patients with sickle cell disease. Get the full story at our sister site, Drug Delivery Business News.   The post Gamida Cell launches severe aplastic anemia trial appeared first on MassDevice. (Source: Mass Device)
Source: Mass Device - August 21, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Research & Development Stem Cells Gamida Cell Source Type: news

Gamida Cell Announces First Patient Transplanted in Phase 1/2 Study of CordIn for Severe Aplastic Anemia and Hypoplastic MDS
This investigator initiated study is being conducted in collaboration with the U.S. National Heart, Lung and Blood Institute (NHLBI) JERUSALEM, Aug. 21, 2017 -- (Healthcare Sales & Marketing Network) -- The first subject has been transplanted in an in... Biopharmaceuticals Gamida Cell, Cordin, aplastic anemia, myelodysplastic syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 21, 2017 Category: Pharmaceuticals Source Type: news

What Causes Anemia?
Discussion One of the most common problems in pediatrics is anemia. It is defined as “a lower than normal value for the related measurements of hemoglobin, hematocrit, and number of red blood cells”, usually 2 standard deviations below the normal for age. Normal hematological values change with age. For a discussion of which values are used click here. The most common type of anemia in childhood is iron deficiency which is commonly caused by inadequate stores (e.g. premature infant), inadequate intake (e.g. poor nutrition) or blood loss (e.g. menses). Anemia screening is recommended at age 9-12 months, and for...
Source: PediatricEducation.org - May 15, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Snapchat's Marie Curie Filter Includes Makeup And People Aren't Happy
Snapchat unveiled a few new photo filters for International Women’s Day on Wednesday, and one of them is ... a problem. To celebrate the day, the app rolled out filters honoring famous women: Frida Kahlo, Rosa Parks, and Marie Curie. The intention to be inclusive is there and appreciated. But there’s an issue with the Marie Curie filter ― she’s inexplicably got a smoky eye and fake eyelashes.  Shoutout to @Snapchat for adding eyelashes to the Marie Curie filter. Forgot that's what she was famous for. #InternationalWomensDay pic.twitter.com/4gN2QjzR5B— Katy St Clair (@Selfies_AndCat...
Source: Science - The Huffington Post - March 8, 2017 Category: Science Source Type: news

Parents make tough decision to save sick son by having a 'saviour sibling'
Mohamad Al Sabbagh has severe idiopathic aplastic anemia. Hoping to save his life with the right match for a stem cell transplant, his parents are considering having a baby and implanting the infant's stem cells into their son. (Source: CBC | Health)
Source: CBC | Health - March 8, 2017 Category: Consumer Health News Tags: News/Canada/Toronto Source Type: news

Sixteen aplastic anemia patients free of disease after bone marrow transplant and chemo
Physicians report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - February 7, 2017 Category: Science Source Type: news

16 aplastic anemia patients free of disease after bone marrow transplant and chemo
(Johns Hopkins Medicine) Physicians at the Johns Hopkins Kimmel Cancer Center report they have successfully treated 16 patients with a rare and lethal form of bone marrow failure called severe aplastic anemia using partially matched bone marrow transplants followed by two high doses of a common chemotherapy drug. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - February 7, 2017 Category: Cancer & Oncology Source Type: news

Veterans Exposed To Contaminated Water At Marine Base To Receive Disability Benefits
WASHINGTON, Jan 12 (Reuters) - The Obama administration has agreed to provide disability benefits to military veterans exposed to contaminated drinking water while at Camp Lejeune in North Carolina, according to an official notice published on Thursday. Veterans, former reservists and former National Guard members who served for at least 30 days at the U.S. Marine Corps Base from 1953 to 1987 and have been diagnosed with one of eight diseases are eligible, according to the document published in the Federal Register, the government’s official journal. The Associated Press, which first reported the story, said the esti...
Source: Healthy Living - The Huffington Post - January 13, 2017 Category: Consumer Health News Source Type: news

VA ’s Rule Establishes a Presumption of Service Connection for Diseases Associated with Exposure to Contaminants in the Water Supply at Camp Lejeune
The U.S. Department of Veterans Affairs (VA) announced that it has established a presumption of service connection for eight diseases that may be associated with exposure to contamination in the water supply at Camp Lejeune in North Carolina from August 1, 1953 to December 31, 1987. This will make it easier for veterans to receive the care and benefits they need. The eight diseases are adult leukemia, aplastic anemia and other myelodysplatic syndromes, bladder, kidney, or liver cancer, multiple myeloma, non-Hodgkin's lymphoma, and Parkinson's disease. (Source: News stories via the Rural Assistance Center)
Source: News stories via the Rural Assistance Center - January 13, 2017 Category: Rural Health Source Type: news

Implants in patients with anemia?
Have any of you installed implants in patients with well controlled, aplastic anemia or hemolytic anemia? (Source: Dental Implants Discussed by Experts)
Source: Dental Implants Discussed by Experts - January 10, 2017 Category: Dentistry Authors: osseonews Tags: Clinical Questions Surgical Source Type: news

Chinese herbal treatment shows signs of effectiveness in bone marrow recovery
FINDINGSUCLA researchers have found that a Chinese herbal regimen called TSY-1 (Tianshengyuan-1) increased telomerase activity in normal blood cells but decreased it in cancer cells. Telomerase is an enzyme responsible for the production of telomeres, which play an important role in the regulation of normal cell division. These results indicate that telomerase-based treatments may play an important role in treating both blood cell deficiency and cancer.BACKGROUNDMore than 80 percent of cancers have increased telomerase activity, and other medical conditions are also associated with decreased or abnormal telomerase function...
Source: UCLA Newsroom: Health Sciences - December 15, 2016 Category: Universities & Medical Training Source Type: news

Male hormone reverses cell aging in clinical trial
Telomerase, an enzyme naturally found in the human organism, is the closest of all known substances to a "cellular elixir of youth." In a recent study, Brazilian and US researchers show that sex hormones can stimulate production of this enzyme. The strategy was tested in patients with genetic diseases associated with mutations in the gene that codes for telomerase, such as aplastic anemia and pulmonary fibrosis. (Source: World Pharma News)
Source: World Pharma News - July 25, 2016 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news

Male hormone reverses cell aging in clinical trial
( Funda ç ã o de Amparo à Pesquisa do Estado de S ã o Paulo ) In a recent study, researchers show that sex hormones can stimulate production of telomerase, an enzyme naturally found in the human organism. The strategy was tested in patients with genetic diseases associated with mutations in the gene that codes for this enzyme, such as aplastic anemia and pulmonary fibrosis. The authors say that the results suggest that the approach can combat the damage caused to the organism by telomerase deficiency. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 25, 2016 Category: Global & Universal Source Type: news

Regen BioPharma, Inc. Discusses Recent Developments in Aplastic Anemia Therapy and Future Potential Expansion of HemaXellerate
SAN DIEGO, May 11, 2016 -- (Healthcare Sales & Marketing Network) -- Regen BioPharma, Inc., (RGBP), (RGBP) and (RGBPP) announced today that potential market expansion of its HemaXellerate therapy for aplastic anemia is a strategic priority. The Compan... Biopharmaceuticals, Regenerative MedicineRegen BioPharma, HemaXellerate, aplastic anemia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2016 Category: Pharmaceuticals Source Type: news

What Are Common Causes of Congenital Aplastic Anemia?
Discussion Aplastic anemia are disorders where there is inadequate production of erythrocytes, granulocytes and platelets caused by decreased bone marrow production leading to a peripheral blood pancytopenia. Most often it is acquired because of exposures to infections (especially viruses such as Epstein-Barr virus, rubella, herpes, etc.), drugs (e.g. chloramphenicol, chemotherapeutic agents, etc.), toxins or radiation. Learning Point The most common congenital bone marrow failure syndromes causing pancytopenia are (in this order) Fanconi anemia, Diamond-Blackfan anemia, and Shwachman-Diamond anemia. Most have a variety of...
Source: PediatricEducation.org - April 17, 2016 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Aplastic anemia or dyskeratosis congenita? Unclear diagnosis forces a difficult decision
Having a child diagnosed with a life-threatening illness is heart-wrenching for all parents, but when the diagnosis itself is uncertain, parents can face excruciatingly difficult decisions. This is what Katie and Josh Stevens of Idaho confronted after their son Riley was diagnosed in October 2012 with the blood disorder aplastic anemia, in which the body’s bone marrow produces too few oxygen-carrying red blood cells, too few infection-fighting white blood cells and too few clot-promoting platelets. He was an 11-year-old skier and runner who was tired, bruised and unable to shake a cold. When his blood was drawn, he b...
Source: Thrive, Children's Hospital Boston - March 9, 2016 Category: Pediatrics Authors: Irene Sege Tags: Diseases & Conditions Our Patients’ Stories Akiko Shimamura Aplastic anemia Bone marrow Failure Program Dana-Farber/Boston Children's Cancer and Blood Disorders Center stem cell transplant Suneet Agarwal Source Type: news

Aplastic Anemia Yields to Promacta (CME/CE)
(MedPage Today) -- Response rates rise for first time in 3 decades with oral agent (Source: MedPage Today Meeting Coverage)
Source: MedPage Today Meeting Coverage - December 7, 2015 Category: Journals (General) Source Type: news

Sam Kimura embarks on road trip in search to find a bone marrow donor
Sam (left) and Alex (right) Kimura from Louisville, Kentucky, started their journey in January, five years after 23-year-old Sam was diagnosed with severe aplastic anemia. (Source: the Mail online | Health)
Source: the Mail online | Health - November 9, 2015 Category: Consumer Health News Source Type: news

Five years after stem cell transplant complications, he’s an active teenager
Drew at 2014 Be the Match Walk in NYC. His stem cell donor lives in Germany. “It’s eye-opening to realize how fragile life really is when you’re young.” Drew D’Auteuil certainly knows whereof he speaks. He is a 16-year-old animal-loving, skiing, rowing, volleyball-playing, honor roll student and licensed driver with braces and a shock of red hair. In April 2010, five months after receiving a stem cell transplant to treat the blood disorder severe aplastic anemia, Drew suffered rare, life-threatening complications. One day Drew was biking with a friend near his New Hampshire home, sufferin...
Source: Thrive, Children's Hospital Boston - November 5, 2015 Category: Pediatrics Authors: Irene Sege Tags: All posts Cancer Diseases & conditions Allison O'Neill Aplastic anemia Dana-Farber/ Children's Hospital Cancer Center stem cell transplant Source Type: news

New avenue for combating deterioration in blood stem cells
Using mouse embryos, researchers have replicated the deterioration with aging of blood stem cells, particularly red blood cells, and were able to alleviate the fetal anemia suffered by the mouse embryos and prevent death in 40 percent of the cases. This is a first step towards the development of potential treatments for anemia caused by a deficient activity of these stem cells, such as the aplastic anemia in cancer patients receiving chemotherapy and radiation therapy. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - October 15, 2015 Category: Science Source Type: news

The CNIO opens up a new avenue for combating the deterioration in blood stem cells
(Centro Nacional de Investigaciones Oncologicas (CNIO)) Using mouse embryos, researchers have replicated the deterioration with aging of blood stem cells, particularly red blood cells, and were able to alleviate the fetal anemia suffered by the mouse embryos and prevent death in 40 percent of the cases.This is a first step towards the development of potential treatments for anemia caused by a deficient activity of these stem cells, such as the aplastic anemia in cancer patients receiving chemotherapy and radiation therapy. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 15, 2015 Category: Cancer & Oncology Source Type: news

Unstoppable Sisters Traveling To All 50 States To Find Bone Marrow Donors
View More: Live News|More News Videos.cbs-link {color:#4B5054;text-decoration:none; font: normal 12px Arial;}.cbs-link:hover {color:#A7COFF;text-decoration:none; font: normal 12px Arial;}.cbs-pipe {color:#303435;padding: 0 2px;}.cbs-resources {height:24px; background-color:#000; padding: 0 0 0 8px; width: 612px;}.cbs-more {font: normal 12px Arial; color: #4B5054; padding-right:2px;} These two sisters are on a road trip for change. Sam and Alex Kimura are on a cross-country road trip to rally people to join the National Bone Marrow Registry and to find a donor for Sam, CBS News reported. The 22-year-old has severe apla...
Source: Science - The Huffington Post - September 22, 2015 Category: Science Source Type: news

Boy with Aplastic Anaemia will be saved by sister with donated stem cells
Scott Anderson, six, from Newcastle, suffers from Aplastic Anaemia, a rare illness which means his bone marrow is not making red blood cells, leaving him at risk of catching killer infections at any time. (Source: the Mail online | Health)
Source: the Mail online | Health - July 8, 2015 Category: Consumer Health News Source Type: news

In Aplastic Anemia, Only a Few Genes Matter (CME/CE)
(MedPage Today) -- Gene mutations identified to help select treatment for aplastic anemia patients (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - July 2, 2015 Category: Geriatrics Source Type: news

Longer Donor Telomeres May Confer Survival After Cell TransplantLonger Donor Telomeres May Confer Survival After Cell Transplant
Longer donor leukocyte telomeres may mean longer survival for aplastic anemia patients who undergo hematopoeitic cell transplantation (HCT), new findings show. Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - February 19, 2015 Category: Pathology Tags: Internal Medicine News Source Type: news

The Story Of Sharing America’s Marrow
(L-R) Taylor Shorten, Sam Kimura and Alex Kimura (photo courtesy of SAM) Two sisters and their best friend have set off on a courageous journey across the country to visit over 190 cities with a goal of registering 50,000 blood marrow donors.Alex and Sam Kimura of Louisville, Kentucky are the co-founders of Sharing America’s Marrow (SAM), a grassroots movement created years after Sam was diagnosed at age 17 with the rare bone marrow disease severe aplastic anemia. Although the cure is a blood marrow transplant, Sam, now 22, has been unable to find a match. With the support of Delete Blood Cancer DKMS, the two sisters...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 18, 2015 Category: Consumer Health News Authors: mjweiss33 Tags: Boston's Best Family & Pets Health Alex Kimura Best Of blood cancer blood diseases bone marrow diseases bone marrow donors Delete Blood Cancer Donor Jam Louisville Kentucky Randy Yagi Sam Sam Kimura severe aplastic anemia S Source Type: news

Your NEJM Group Today: Marginal Healthcare, Longer Telomeres for Aplastic Anemia, Virginia Hospitalist Opportunities (FREE)
By The Editors NEJM Group offers so many valuable resources for practicing clinicians. Here's what we chose for you today:NEJM … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - February 11, 2015 Category: Primary Care Source Type: news

GSK seeks European approval for eltrombopag to treat severe aplastic anaemia
British drug-maker GlaxoSmithKline (GSK) has submitted a marketing authorisation application to the European Medicines Agency (EMA) seeking an additional indication for eltrombopag (Revolade). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 13, 2014 Category: Pharmaceuticals Source Type: news

Gene mutation discovered in blood disorder aplastic anemia
A gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells, has been discovered by an international team of scientists. The gene regulates telomeres on the ends of chromosomes. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - September 23, 2014 Category: Science Source Type: news

Gene mutation discovered in blood disorder
(Children's Hospital of Philadelphia) An international team of scientists has identified a gene mutation that causes aplastic anemia, a serious blood disorder in which the bone marrow fails to produce normal amounts of blood cells. Studying a family in which three generations had blood disorders, the researchers discovered a defect in a gene that regulates telomeres, chromosomal structures with crucial roles in normal cell function. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 23, 2014 Category: Global & Universal Source Type: news

Back in the game after stem cell transplant
By Irene Sege Some 100 days after receiving a stem cell transplant to cure his severe aplastic anemia, Behaylu Barry still couldn’t invite friends into his home. He wouldn’t be returning to school until January because his immune system needs the time to get strong enough to fight the pathogens present in indoor spaces. But 13-year-old Behaylu was doing so well that his doctor cleared him to play soccer – outdoors, of course — for the first time since February, when he was diagnosed with the life-threatening blood disorder shortly before he was to join the competitive soccer team that had just selec...
Source: Thrive, Children's Hospital Boston - September 8, 2014 Category: Pediatrics Authors: Guest Blogger Tags: All posts Aplastic anemia Dana-Farber/Boston Children's Transplant center Stem cell Stem Cell Transplant Program Source Type: news

FDA clears GSK’s Promacta sNDA to treat SAA patients
The US Food and Drug Administration (FDA) has given its clearance to supplemental new drug application (sNDA) for GlaxoSmithKline's (GSK) Promacta (eltrombopag) to treat patients with severe aplastic anaemia (SAA). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 28, 2014 Category: Pharmaceuticals Source Type: news